Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-004198
Filing Date
2023-10-03
Accepted
2023-10-03 16:42:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 6526
  Complete submission text file 0001959173-23-004198.txt   8021
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Subject) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40323 | Film No.: 231304624
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RECURSION PHARMACEUTICALS 41 S. RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address
Borgeson Blake (Reporting) CIK: 0001856094 (see all company filings)

Type: 144